Here, Hichem Tasfaout & team describe a new method for using proteomics to evaluate the efficacy of three dystrophin-replacement approaches using AAV vectors.
1Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota — Twin Cities, Minneapolis, Minnesota, USA.
2Department of Neurology.
3Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, and.
4Department of Biochemistry, University of Washington School of Medicine, Seattle, Washington, USA.